Novasep, a leading supplier of services and technologies for the life sciences industry, announced a €6.1 million (...
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26...
SP Scientific Products (SP) announces the launch of its SP Hull LyoStar® 4.0 R&D and process developme...
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...
Vectura Group has signed an agreement with Australia-based Incannex Healthcare to provide pre-clinical development servi...
Germany-based Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation researc...
Researchers are developing a rapid, low cost and mass manufacturable saliva-based biosensor test for COVID-19 inspired b...
Pizzie brings more than thirty years of commercial and operating experience in the life sciences and biotechnology secto...
In a landmark agreement at G7 summit, held in Cornwall, UK, global leaders have pledged to share COVID-19 vaccine doses ...
A team of clinicians and scientists from the National University Cancer Institute, Singapore (NCIS) at the National Univ...
Verona Pharma plc and Nuance Pharma Limited have entered into an agreement granting Nuance Pharma, a Shanghai-based...
LivFul and Global Access Diagnostics (GAD) announced a new partnership to make a variety of diagnostic kits, starting wi...
3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the ...
Biolog-id, a global service provider of connected healthcare solutions, announce on June 4, 2021 the opening of a regist...
Europes' Epillo Health Systems. a unique integrated mobile application for patients, electronic Health record (EHR) syst...
For the second time in a row, Vetter, a global leading contract development and manufacturing organisation (CDMO), ...
Sosei Group Corporation has been notified by Pfizer that the first subject in a clinical trial has been dosed with a new...
London-based Bioventures Abingworth finance/manages late-stage phase III developments. It has announced the final clos...
